Common use of At-Market Transaction Clause in Contracts

At-Market Transaction. Notwithstanding Section 2(f)(i) above and subject to the prior approval of the Nasdaq Capital Market or any other Principal Market on which the Common Stock may be listed or quoted (to the extent required), the Exchange Cap shall not be applicable for any purposes of this Agreement and the transactions contemplated hereby, solely to the extent that (and only for so long as) the Average Price shall equal or exceed the Base Price and in accordance with any other applicable rules of the Nasdaq Capital Market or any other Principal Market on which the Common Stock may be listed or quoted (it being hereby acknowledged and agreed that the Exchange Cap shall be applicable for all purposes of this Agreement and the transactions contemplated hereby at all other times during the term of this Agreement, unless the stockholder approval referred to in Section 2(f)(i) is obtained). “Base Price” means a price per Purchase Share equal to the sum of (i) the Signing Market Price and (ii) $0.1533 (subject to adjustment for any reorganization, recapitalization, non-cash dividend, stock split, reverse stock split or other similar transaction that occurs on or after the date of this Agreement). “Signing Market Price” means $2.61, representing the lower of (i) the Nasdaq Official Closing Price of the Common Stock as reported on the Nasdaq Capital Market immediately preceding the date of this Agreement or (ii) the average of the Nasdaq Official Closing Prices of the Common Stock as reported on The Nasdaq Capital Market for the five (5) Business Days immediately preceding the signing of this Agreement.

Appears in 1 contract

Samples: Purchase Agreement (Genocea Biosciences, Inc.)

AutoNDA by SimpleDocs

At-Market Transaction. Notwithstanding Section 2(f)(i) above and subject to the prior approval of the Nasdaq Capital Global Market or any other Principal Market on which the Common Stock may be listed or quoted (to the extent required), the Exchange Cap shall not be applicable for any purposes of this Agreement and the transactions contemplated hereby, solely to the extent that (and only for so long as) the Average Price shall equal or exceed the Base Price and in accordance with any other applicable rules of the Nasdaq Capital Global Market or any other Principal Market on which the Common Stock may be listed or quoted (it being hereby acknowledged and agreed that the Exchange Cap shall be applicable for all purposes of this Agreement and the transactions contemplated hereby at all other times during the term of this Agreement, unless the stockholder approval referred to in Section 2(f)(i) is obtained). “Base Price” means a price per Purchase Share equal to the sum of (i) the Signing Market Price and (ii) $0.1533 0.0706 (subject to adjustment for any reorganization, recapitalization, non-cash dividend, stock split, reverse stock split or other similar transaction that occurs on or after the date of this Agreement). “Signing Market Price” means $2.611.4500, representing the lower of (i) the Nasdaq Official Closing Price closing price of the Common Stock as reported on the Nasdaq Capital Global Market immediately preceding the date of this Agreement or (ii) the average of the Nasdaq Official Closing Prices closing price of the Common Stock as reported on The the Nasdaq Capital Global Market for the five (5) Business Days immediately preceding the signing of this Agreement.

Appears in 1 contract

Samples: Purchase Agreement (T2 Biosystems, Inc.)

At-Market Transaction. Notwithstanding Section 2(f)(i) above and subject to the prior approval of the Nasdaq Capital Market or any other Principal Market on which the Common Stock may be listed or quoted (to the extent required), the Exchange Cap shall not be applicable for any purposes of this Agreement and the transactions contemplated hereby, solely to the extent that (and only for so long as) the Average Price shall equal or exceed the Base Price and in accordance with any other applicable rules of the Nasdaq Capital Market or any other Principal Market on which the Common Stock may be listed or quoted (it being hereby acknowledged and agreed that the Exchange Cap shall be applicable for all purposes of this Agreement and the transactions contemplated hereby at all other times during the term of this Agreement, unless the stockholder approval referred to in Section 2(f)(i2(e)(i) is obtained). “Base Price” means a price per Purchase Share equal to the sum of (i) the Signing Market Price and (ii) $0.1533 0.3858 (subject to adjustment for any reorganization, recapitalization, non-cash dividend, stock split, reverse stock split or other similar transaction that occurs on or after the date of this Agreement). “Signing Market Price” means $2.613.8420, representing the lower of (i) the Nasdaq Official Closing Price closing price of the Common Stock as reported on the Nasdaq Capital Market immediately preceding the date of this Agreement or (ii) the average of the Nasdaq Official Closing Prices closing price of the Common Stock as reported on The the Nasdaq Capital Market for the five (5) Business Days immediately preceding the signing of this Agreement.

Appears in 1 contract

Samples: Purchase Agreement (Caladrius Biosciences, Inc.)

AutoNDA by SimpleDocs

At-Market Transaction. Notwithstanding Section 2(f)(i2(e)(i) above and subject to the prior approval of the Nasdaq Capital Global Select Market or any other Principal Market on which the Common Stock may be listed or quoted (to the extent required), the Exchange Cap shall not be applicable for any purposes of this Agreement and the transactions contemplated hereby, solely to the extent that (and only for so long as) the Average Price shall equal or exceed the Base Price and in accordance with any other applicable rules of the Nasdaq Capital Global Select Market or any other Principal Market on which the Common Stock may be listed or quoted (it being hereby acknowledged and agreed that the Exchange Cap shall be applicable for all purposes of this Agreement and the transactions contemplated hereby at all other times during the term of this Agreement, unless the stockholder approval referred to in Section 2(f)(i2(e)(i) is obtained). “Base Price” means a price per Purchase Share equal to the sum of (i) the Signing Market Price and (ii) $0.1533 0.10 (subject to adjustment for any reorganization, recapitalization, non-cash dividend, stock split, reverse stock split or other similar transaction that occurs on or after the date of this Agreement). “Signing Market Price” means $2.611.40, representing the lower of (i) the Nasdaq Official Closing Price closing price of the Common Stock as reported on the The Nasdaq Capital Global Select Market immediately preceding on the date of this Agreement or (ii) the average of the Nasdaq Official Closing Prices of the Common Stock as reported on The Nasdaq Capital Market for the five (5) Business Days immediately preceding the signing of this Agreement.

Appears in 1 contract

Samples: Purchase Agreement (Aptevo Therapeutics Inc.)

Time is Money Join Law Insider Premium to draft better contracts faster.